Article

Development and clinical validation of molecular subgrouping in medulloblastoma by targeted methylation sequencing

2023-12-11

Abstract excerpt

<h4>Background</h4> The WHO classification of CNS tumors confers promising prognostic value to the molecular classification of medulloblastoma (MB). Next-generation sequencing (NGS) has been the primary method employed for molecular classification through transcriptomic, genomic, or methylation profiling. However, due to cost and infrastructural needs, particularly in developing countries, we propose a relatively...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b93a4ca4-606a-5803-a5a9-bfd9394e2ecd
DOI: 10.1101/2023.12.08.570900

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development and clinical validation of molecular subgrouping in medulloblastoma by targeted methylation sequencingDOI 10.1101/2023.12.08.570900Read

Childhood Medulloblastoma: Current Therapies, Emerging Molecular Landscape and Newer Therapeutic InsightsSemantic proximity Read

A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma.Semantic proximity Read

Methylation Profiling of Medulloblastoma in a Clinical Setting Permits Sub-classification and Reveals New Outcome PredictionsSemantic proximity Read

DNA-methylation profiling discloses significant advantages over NanoString method for molecular classification of medulloblastomaSemantic proximity Read

The molecular classification of medulloblastomaSemantic proximity Read

Medulloblastoma genomics in the modern molecular eraSemantic proximity Read

Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical PracticeSemantic proximity Read

Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arraysSemantic proximity Read

DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsiesSemantic proximity Read

Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma TreatmentSemantic proximity Read

Molecular subgroups of medulloblastoma: the current consensusSemantic proximity Read

New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology.Semantic proximity Read